{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T05:10:01Z","timestamp":1735017001122,"version":"3.32.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,23]]},"DOI":"10.7759\/cureus.76245","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T11:37:45Z","timestamp":1734953865000},"source":"Crossref","is-referenced-by-count":0,"title":["Retrospective Cohort Analysis of Class II Human Leukocyte Antigen (HLA) Alleles in Children With Steroid-Dependent Nephrotic Syndrome Treated With Cyclophosphamide"],"prefix":"10.7759","author":[{"given":"Sehrish","family":"Javed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aasia","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habib","family":"Qaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Asghar A","family":"Lanewala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khawar","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajiha","family":"Musharraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone DG","year":"2018","unstructured":"Noone DG, Ijima K, Parekh R. Idiopathic nephrotic syndrome in children. Lancet. 2018, 392:61-74. 10.1016\/S0140-6736(18)30536-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-04983-3","article-title":"Update on the treatment of steroid-sensitive nephrotic syndrome","volume":"37","author":"Zotta F","year":"2022","unstructured":"Zotta F, Vivarelli M, Emma F. Update on the treatment of steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2022, 37:303-14. 10.1007\/s00467-021-04983-3","journal-title":"Pediatr Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05739-3","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","volume":"38","author":"Trautmann A","year":"2023","unstructured":"Trautmann A, Boyer O, Hodson E, et al.. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2023, 38:877-919. 10.1007\/s00467-022-05739-3","journal-title":"Pediatr Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2018.06.436","article-title":"Histopathological spectrum and short-term outcome of treatment with cyclophosphamide in relapsing steroid-sensitive nephrotic syndrome","volume":"28","author":"Bajeer IA","year":"2018","unstructured":"Bajeer IA, Khatri S, Tresa V, Hashmi S, Mubarak M, Lanewala AA. Histopathological spectrum and short-term outcome of treatment with cyclophosphamide in relapsing steroid-sensitive nephrotic syndrome. J Coll Physicians Surg Pak. 2018, 28:436-9. 10.29271\/jcpsp.2018.06.436","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-05401-4","article-title":"An updated view of the pathogenesis of steroid-sensitive nephrotic syndrome","volume":"37","author":"Horinouchi T","year":"2022","unstructured":"Horinouchi T, Nozu K, Iijima K. An updated view of the pathogenesis of steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2022, 37:1957-65. 10.1007\/s00467-021-05401-4","journal-title":"Pediatr Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v10.i5.88","article-title":"Trends in pediatric nephrotic syndrome","volume":"10","author":"Tamura H","year":"2021","unstructured":"Tamura H. Trends in pediatric nephrotic syndrome. World J Nephrol. 2021, 10:88-100. 10.5527\/wjn.v10.i5.88","journal-title":"World J Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9710376","article-title":"Human leukocyte antigen (HLA) system: genetics and association with bacterial and viral infections","volume":"2022","author":"Medhasi S","year":"2022","unstructured":"Medhasi S, Chantratita N. Human leukocyte antigen (HLA) system: genetics and association with bacterial and viral infections. J Immunol Res. 2022, 2022:9710376. 10.1155\/2022\/9710376","journal-title":"J Immunol Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1980.13","article-title":"HLA, atopy, and cyclophosphamide in steroid-responsive childhood nephrotic syndrome","volume":"17","author":"Trompeter RS","year":"1980","unstructured":"Trompeter RS, Barratt TM, Kay R, Turner MW, Soothill JF. HLA, atopy, and cyclophosphamide in steroid-responsive childhood nephrotic syndrome. Kidney Int. 1980, 17:113-7. 10.1038\/ki.1980.13","journal-title":"Kidney Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-05052-5","article-title":"Oral cyclophosphamide therapy in 100 children with steroid-sensitive nephrotic syndrome: experience from a developing country","volume":"36","author":"Sandhu J","year":"2021","unstructured":"Sandhu J, Bhat D, Dhooria GS, Pooni PA, Bhargava S, Kakkar S, Gill KS. Oral cyclophosphamide therapy in 100 children with steroid-sensitive nephrotic syndrome: experience from a developing country. Pediatr Nephrol. 2021, 36:2759-67. 10.1007\/s00467-021-05052-5","journal-title":"Pediatr Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.32598\/jpr.12.2.1190.1","article-title":"A systematic review on the risk factors of steroid-sensitive nephrotic syndrome relapse in the pediatric population","volume":"10","author":"Yousefifard M","year":"2024","unstructured":"Yousefifard M, Ahmadzadeh K, Madani Neishaboori A, et al.. A systematic review on the risk factors of steroid-sensitive nephrotic syndrome relapse in the pediatric population. J Pediatr Rev. 2024, 10:10.32598\/jpr.12.2.1190.1","journal-title":"J Pediatr Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-04955-7","article-title":"HLA-DQ and HLA-DRB1 alleles associated with Henoch-Sch\u00f6nlein purpura nephritis in Finnish pediatric population: a genome-wide association study","volume":"36","author":"Koskela M","year":"2021","unstructured":"Koskela M, Nihtil\u00e4 J, Ylinen E, Kolho KL, Nuutinen M, Ritari J, Jahnukainen T. HLA-DQ and HLA-DRB1 alleles associated with Henoch-Sch\u00f6nlein purpura nephritis in Finnish pediatric population: a genome-wide association study. Pediatr Nephrol. 2021, 36:2311-8. 10.1007\/s00467-021-04955-7","journal-title":"Pediatr Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1101\/2022.09.13.22279644","article-title":"Multi-population genome-wide association study implicates both immune and non-immune factors in the etiology of pediatric steroid sensitive nephrotic syndrome","volume":"14","author":"Barry A","year":"2022","unstructured":"Barry A, McNulty MT, Jia X, et al.. Multi-population genome-wide association study implicates both immune and non-immune factors in the etiology of pediatric steroid sensitive nephrotic syndrome. medRxiv. 2022, 14:2022-09. 10.1101\/2022.09.13.22279644","journal-title":"medRxiv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.18021120","article-title":"HLA alleles and prognosis of PLA2R-related membranous nephropathy","volume":"16","author":"Le WB","year":"2021","unstructured":"Le WB, Shi JS, Fan Y, Gong SW. HLA alleles and prognosis of PLA2R-related membranous nephropathy. Clin J Am Soc Nephrol. 2021, 16:1221-7. 10.2215\/CJN.18021120","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1124249","article-title":"The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis","volume":"14","author":"Batal I","year":"2023","unstructured":"Batal I, Khairallah P, Weins A, Andeen NK, Stokes MB. The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis. Front Immunol. 2023, 14:1124249. 10.3389\/fimmu.2023.1124249","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.598665","article-title":"HLA-Drb1(*)04 as a risk allele to systemic lupus erythematosus and lupus nephritis in the Malay population of Malaysia","volume":"7","author":"Selvaraja M","year":"2020","unstructured":"Selvaraja M, Chin VK, Abdullah M, Arip M, Amin-Nordin S. HLA-Drb1(*)04 as a risk allele to systemic lupus erythematosus and lupus nephritis in the Malay population of Malaysia. Front Med (Lausanne). 2020, 7:598665. 10.3389\/fmed.2020.598665","journal-title":"Front Med (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-021-00489-y","article-title":"Association between HLA alleles and sub-phenotype of childhood steroid-sensitive nephrotic syndrome","volume":"18","author":"Lee H","year":"2022","unstructured":"Lee H, Wang L, Ni FF, et al.. Association between HLA alleles and sub-phenotype of childhood steroid-sensitive nephrotic syndrome. World J Pediatr. 2022, 18:109-19. 10.1007\/s12519-021-00489-y","journal-title":"World J Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017080859","article-title":"Strong association of the HLA-DR\/DQ locus with childhood steroid-sensitive nephrotic syndrome in the Japanese population","volume":"29","author":"Jia X","year":"2018","unstructured":"Jia X, Horinouchi T, Hitomi Y, et al.. Strong association of the HLA-DR\/DQ locus with childhood steroid-sensitive nephrotic syndrome in the Japanese population. J Am Soc Nephrol. 2018, 29:2189-99. 10.1681\/ASN.2017080859","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014030247","article-title":"HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome","volume":"26","author":"Gbadegesin RA","year":"2015","unstructured":"Gbadegesin RA, Adeyemo A, Webb NJ, et al.. HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome. J Am Soc Nephrol. 2015, 26:1701-10. 10.1681\/ASN.2014030247","journal-title":"J Am Soc Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1347-5","article-title":"Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan","volume":"20","author":"Moorani KN","year":"2019","unstructured":"Moorani KN, Hotchandani HM, Zubair AM, Lohana NC, Veerwani NR. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan. BMC Nephrol. 2019, 20:239. 10.1186\/s12882-019-1347-5","journal-title":"BMC Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03739-z","article-title":"Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study","volume":"25","author":"Dhooria GS","year":"2024","unstructured":"Dhooria GS, Bhargava S, Bhat D, Pooni PA, Goel N, Kakkar S. Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study. BMC Nephrol. 2024, 25:296. 10.1186\/s12882-024-03739-z","journal-title":"BMC Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2015.1073051","article-title":"The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome","volume":"37","author":"Din\u00e7el N","year":"2015","unstructured":"Din\u00e7el N, Y\u0131lmaz E, Kaplan Bulut \u0130, Hac\u0131kara \u015e, Mir S. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome. Ren Fail. 2015, 37:1267-72. 10.3109\/0886022X.2015.1073051","journal-title":"Ren Fail"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/pnjb.pnjb_15_23","article-title":"Familial nephrotic syndrome: does it matter?","volume":"8","author":"Quader MM","year":"2023","unstructured":"Quader MM. Familial nephrotic syndrome: does it matter?. Paediatr Neph J Bangladesh. 2023, 8:69-77. 10.4103\/pnjb.pnjb_15_23","journal-title":"Paediatr Neph J Bangladesh"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12669","article-title":"Association of HLA-DR\/DQ alleles and haplotypes with nephrotic syndrome","volume":"21","author":"Ramanathan AS","year":"2016","unstructured":"Ramanathan AS, Senguttuvan P, Chinniah R, et al.. Association of HLA-DR\/DQ alleles and haplotypes with nephrotic syndrome. Nephrology (Carlton). 2016, 21:745-52. 10.1111\/nep.12669","journal-title":"Nephrology (Carlton)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050224","article-title":"HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome","volume":"11","author":"Konrad M","year":"1997","unstructured":"Konrad M, Mytilineos J, Ruder H, Opelz G, Sch\u00e4rer K. HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 1997, 11:16-9. 10.1007\/s004670050224","journal-title":"Pediatr Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s004670000416","article-title":"HLA-DRB1 alleles in Kuwaiti children with idiopathic nephrotic syndrome","volume":"15","author":"Al-Eisa AA","year":"2000","unstructured":"Al-Eisa AA, Haider MZ, Srivasta BS. HLA-DRB1 alleles in Kuwaiti children with idiopathic nephrotic syndrome. Pediatr Nephrol. 2000, 15:79-81. 10.1007\/s004670000416","journal-title":"Pediatr Nephrol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.05.018","article-title":"Common risk variants in AHI1 are associated with childhood steroid sensitive nephrotic syndrome","volume":"8","author":"Downie ML","year":"2023","unstructured":"Downie ML, Gupta S, Voinescu C, et al.. Common risk variants in AHI1 are associated with childhood steroid sensitive nephrotic syndrome. Kidney Int Rep. 2023, 8:1562-74. 10.1016\/j.ekir.2023.05.018","journal-title":"Kidney Int Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/326961-retrospective-cohort-analysis-of-class-ii-human-leukocyte-antigen-hla-alleles-in-children-with-steroid-dependent-nephrotic-syndrome-treated-with-cyclophosphamide","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T11:37:47Z","timestamp":1734953867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/326961-retrospective-cohort-analysis-of-class-ii-human-leukocyte-antigen-hla-alleles-in-children-with-steroid-dependent-nephrotic-syndrome-treated-with-cyclophosphamide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.76245","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,23]]}}}